Table 5.
Adverse events.
| Initially no fistula (n = 55) | Preexisting fistula (n = 26) | Any fistula overall (n = 35) | P value (any fistula versus no fistula) | |||
|---|---|---|---|---|---|---|
| No fistula overall (n = 46) | Fistula during NPWT (n = 5) | Fistula after NPWT (n = 4) | ||||
| Death | 28.6% (13) | 40.0% (2) | 25.0% (1) | 34.6% (9) | 34.3% (12) | 0.63 |
| Bleeding | 15.2% (7) | 0.0% (0) | 25.0% (1) | 3.9% (1) | 5.7% (2) | 0.29 |
| Major organ failure | 26.1% (12) | 20.0% (1) | 25.0% (1) | 38.5% (10) | 34.3% (12) | 0.47 |
| Acute respiratory distress | 4.4% (2) | 0.0% (0) | 0.0% (0) | 3.9% (1) | 2.9% (1) | 1.0 |
| Acute respiratory failure | 4.4% (2) | 0.0% (0) | 0.0% (0) | 3.9% (1) | 2.9% (1) | 1.0 |
| Cholecystitis | 2.2% (1) | 0.0% (0) | 0.0% (0) | 3.9% (1) | 2.9% (1) | 1.0 |
| Mesh infection | 4.4% (2) | 0.0% (0) | 0.0% (0) | 3.9% (1) | 2.9% (1) | 1.0 |
| ventral hernia | 2.2% (1) | 0.0% (0) | 25.0% (1) | 3.9% (1) | 5.7% (2) | 0.58 |
| Wound infection | 2.2% (1) | 0.0% (0) | 0.0% (0) | 7.7% (2) | 5.7% (2) | 0.58 |
| Candida sepsis | 4.4% (2) | 0.0% (0) | 0.0% (0) | 0.0% (0) | 0.0% (0) | 0.50 |
| Sepsis | 6.5% (3) | 0.0% (0) | 25.0% (1) | 11.5% (3) | 11.4% (4) | 0.46 |
| Wound healing Disorder | 2.2% (1) | 0.0% (0) | 0.0% (0) | 7.7% (2) | 5.7% (2) | 0.58 |
| Other | 30.4% (14) | 0.0% (0) | 75.0% (3) | 26.9% (7) | 28.6% (10) | 1.0 |